View Older Stories
-
Solventum (SOLV) PT Raised to $105 at Stifel: A Multi-Year Turnaround Story in Store
-
Piper Sandler: Solventum (SOLV) a Top Idea for 2026
-
Solventum receives top healthcare supply chain certification from HIRC
-
BTIG Upgrades Solventum (SOLV) to Buy
-
UBS Reiterates Neutral Rating on Solventum (SOLV) On Acera Deal & Buy Back Announcement
-
Solventum Corporation (SOLV) Misses Q3 EPS by 27c ; Offers Guidance
-
UBS Starts Solventum (SOLV) at Neutral
-
Jefferies Starts Solventum (SOLV) at Hold
-
Solventum prices $2 billion debt tender offer with premium rates
-
Solventum launches $1.75 billion debt tender offers
-
Solventum Corporation (SOLV) Files for 34.37M Share Offering by 3M Company
-
Solventum (SOLV) PT Raised to $94 at Piper Sandler
-
Solventum Corporation (SOLV) Tops Q2 EPS by 1c ; Offers Guidance
-
Solventum Corporation (SOLV) 2200 contracts of September 75 calls trade
-
Morgan Stanley Upgrades Solventum (SOLV) to Overweight
-
KeyBanc Starts Solventum (SOLV) at Sector Weight
-
Piper Sandler Highlights 'Best Value Stocks' in Medical Technology
-
Piper Sandler Upgrades Solventum (SOLV) to Overweight
-
Solventum Corporation (SOLV) Misses Q1 EPS by 23c ; Offers Guidance
-
Solventum (SOLV) partners with SprintRay
-
Stifel Reiterates Buy Rating on Solventum (SOLV)
-
Solventum (SOLV) PT Raised to $85 at Mizuho
-
Solventum Corporation (SOLV) to Present Value Creation Formula and Long-Range Plan at 2025 Investor Day
-
Solventum (SOLV) PT Raised to $84 at Piper Sandler
-
Solventum Corporation (SOLV) Misses Q4 EPS by 9c ; Offers Guidance
-
Trian says Solventum (SOLV) will deliver faster organic growth and higher margins as standalone company
-
Trian Fund Management to Push Solventum Corporation (SOLV) to Separate More Business Units - WSJ
-
Thermo Fisher Scientific (TMO) to Acquire Solventum’s (SOLV) Purification and Filtration Business for $4.1B Cash
-
Trian Issues Open Letter to Solventum (SOLV) Shareholders
-
Trian's Nelson Peltz Sends Letter to Solventum (SOLV) Holders - CNBC
-
Mizuho Starts Solventum (SOLV) at Neutral
-
Solventum Corporation (SOLV) Launches First 3D Printed Aligner Attachments
-
Solventum (SOLV) PT Raised to $75 at Piper Sandler
-
Solventum Corporation (SOLV) Tops Q3 EPS by 10c; offers guidance
-
Solventum Corporation (SOLV) to Explore Sale of Purification and Filtration Unit - WSJ
-
Solventum Corporation (SOLV) Appoints Ryan Egeland as Chief Medical Officer
-
Stifel Starts Solventum (SOLV) at Buy
-
Piper Sandler Starts Solventum (SOLV) at Neutral
-
BTIG Reiterates Neutral Rating on Solventum (SOLV)
-
Wolfe Research Starts Solventum (SOLV) at Peerperform
-
Solventum Corporation (SOLV) Launches All-In-One, Extended-Wear Wound Dressing for V.A.C. Therapy
-
Morgan Stanley Reiterates Equalweight Rating on Solventum (SOLV)
-
BTIG Starts Solventum (SOLV) at Neutral
-
Solventum Corporation (SOLV) autonomous coding listed in Epic Toolbox
-
Analysts weigh in on Solventum (SOLV) as activist Train builds stake
-
After-hours movers: NXP Semiconductors, Cleveland-Cliffs, Nucor and more
-
Peltz’s Trian Is Said To Build Stake In 3M Spinoff Solventum (SOLV) - Bloomberg
-
MediWound enters PIPE deal, not takeover; sending shares sharply lower
-
BTIG Reiterates Buy Rating on Vericel Corporation (VCEL)
-
MediWound (MDWD) spokesperson won't comment on takeover "rumors"

